“…12 Episodes of AF themselves promote a procoagulant state with an increase in markers of platelet activation (betathromboglobulin and platelet factor 4), thrombogenesis (elevated fibrinogen, prothrombin fragment F1 + 2, thrombin-antithrombin complexes, D-dimer levels) and endothelial dysfunction or injury (elevated von Willebrand factor, soluble E-selectin levels), independent of the presence of structural heart disease, increasing the likelihood of thromboembolism. 6,11,16,22,23,[25][26][27][28][29][30] Evidence also points to endocardial or endothelial dysfunction with decreased anticoagulant mechanisms --such as expression of nitric oxide synthase, tissue factor pathway inhibitor and thrombomodulin --and an increase in procoagulant factors such as plasminogen activator inhibitor-1 22,23,31 as a possible mechanism for thromboembolism in the setting of AF. Inflammation with elevated C-reactive protein and interleukin-6 is associated with a prothrombotic state and an increase in reactive oxygen species production that promotes platelet hyperactivity and additional susceptibility to thrombosis, contributing to an overall hypercoagulable state in AF.…”